Navigation Links
Effective and Safe Cancer Vaccine? Breakthrough Alternative Cancer Treatment Available Through Special Research Program

Austin, TX (PRWEB) October 30, 2013

Despite billions of dollars spent, thousands of clinical trials conducted and hundreds of new pharmaceutical drugs launched, the 50+ year war on cancer has resulted in few victories. Pioneering biomedical scientists at Perseus PCI intend to change that fact with recent approval of an alternative cancer treatment, a therapeutic vaccine, as part of a research program in the Cayman Islands.

Increasingly aggressive regimens of chemotherapy, radiation and surgery have barely moved the needle on death rates for the most common cancers and cause debilitating side effects that often cause death. A breakthrough is clearly needed, and the personalized immunotherapy treatment licensed by Perseus PCI offers compelling new hope to cancer sufferers by teaching the immune system to destroy the engine of cancer inside the body. Based on decades of research from respected scientist, Dr. Thomas Wagner, the therapy arms the immune system to attack the tumor. And it’s achieved while giving patients a quality of life simply not possible with standard treatment protocols.

“This advanced immunotherapy is as far removed from what’s on a hospital’s pharmacy shelves as medicines can get,” says Dr. Wagner. “We are deconstructing and decoding the tumor, and sending the patient’s own T-cells to destroy the systems that supported its spread.”

Dr. Wagner’s work in genetic medicine directed his research to the promise of personalized immunotherapy in the early 1990s. “We learned then that cancer starts in the body 10 times a day, at least, but 99 percent of them are automatically stopped by natural processes. I decided it made a great deal more sense to figure out the mechanisms in the body that stop the cancer and tweak them rather than bomb them with chemotherapy,” he explains.

Toxic, debilitating and ineffective--according to a study in the Journal of Clinical Oncology, the overall contribution of chemotherapy to five-year survival in adult cancer patients is estimated at just 2.1 percent.

The Perseus method inserts the entire molecular content of the patient’s cancerous tumor cells into dendritic cells (special cells that help the immune system recognize cancer). This triggers a massive response by the immune system against that specific type of cancer cell, creating a lifetime immunity to the disease. With immunotherapy, patients experience none of the devastating side effects associated with chemotherapy such as fatigue, hair loss and memory loss.

“Ideally we want to vaccinate at the earliest stages of cancer because we believe we might actually cure the patient’s disease,” asserts Dr. Wagner. “Our research in the U.S. suggests we can extend the late-stage cancer patient’s quality of life and life expectancy, but we can go further.”

The immunotherapy vaccine, now available at the Perseus clinic in the Cayman Islands, has gone through Phases I and II clinical trials in the U.S. for treatment of advanced stage melanoma, renal cell carcinoma and neuroblastoma. Average life expectancy for patients in this category was estimated at three to five months; life span post immunotherapy averaged three years.

Working with a small section of the patient’s solid tumor, and a vial of blood drawn at the first visit, the vaccine is produced in three days, personalized to the patient’s cells. Initial administration of the vaccine takes place on the third day, followed by three subsequent visits at one-month intervals. The only side effects are a low-grade fever.

The cost, which includes preparation and administration of the personalized cancer vaccine, airfare and hotel stays for all four visits, ranges up to $95,000. “Cancer patients frequently spend that much out of pocket for traditional treatments that deplete their resources and severely affect their quality of life,” asserts Dr. Wagner.

Visit or call ?866-299-0750.

DR. THOMAS WAGNER, Ph.D., co-founder of Perseus PCI, is a world-renowned biomedical scientist and innovator who has pioneered some of the past half-century’s most significant biomedical technologies. Learn more about Dr. Wagner

*The Perseus PCI cancer vaccine is approved by the Health Practice Commission of the Cayman Islands for research only. Through Orbis Health Solutions, LLC, additional trials of the immunotherapy vaccine are being pursued in the U.S. and Europe.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. HIV Prevention Pill Cost-Effective for High-Risk Men: Study
2. Pig stomach mucins are effective as anti-viral agents for consumer products
3. Lower-Dose Radioiodine Effective Against Thyroid Cancer
4. Aspirin as Effective as Warfarin for Heart Failure: Study
5. Mayo Clinic: Exhaustion renders immune cells less effective in cancer treatment
6. Breast cancer effectively treated with chemical found in celery, parsley by MU researchers
7. Researchers make promising discovery in pursuit of effective lymphoma treatments
8. Breast MRI helps predict chemotherapys effectiveness
9. Kitchen exhaust fans vary in effectiveness in reducing indoor air pollution
10. New drug found effective against rare form of basal cell skin cancer
11. New Drug Effective for Rare Genetic Skin Cancer: Studies
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has released a ... Mesothelioma has just posted the findings on the website. Click here to read ... of 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... 27th edition of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, ... The digital component is distributed nationally, through a vast social media strategy and ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec Solutions announced ... User Group (MSDSLUG). Recognized as Microsoft’s official group for end users of Dynamics ... software users, partners, industry experts and representatives. Intellitec Solutions’ membership status demonstrates their ...
(Date:11/27/2015)... ... November 27, 2015 , ... CBD College ... Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography program. CBD ... colleges, as only one of twelve colleges and universities in the state of California ...
(Date:11/27/2015)... ... 27, 2015 , ... Indosoft Inc., developer and distributor of ... 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. , Making ... with a version of Asterisk that will receive not only security fixes, but ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... A new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... new combination approach blends immunotherapy with Bremachlorin-photodynamic therapy for ... has found that immunotherapy can be efficiently ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... DUBLIN , Nov. 26, 2015 Research ... of the "Advanced Wound Care Market by Type ... Ulcers), End User (In-Patient Facility, Out-Patient Facility), and Geography ... offering. --> --> ... the description, definition and forecast of the global advanced ...
Breaking Medicine Technology: